RxDoctor Payments Data

Gregory Westin, MD

Vascular Surgery · Indianapolis, INNPI 1659676146

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,083 of the $1,489 with a category attached, or 72.7%. 9 manufacturers reported payments, led by Shape Memory Medical Inc. at 32.9% of the total. Reporting peaked in 2023 at $624 and has fallen 97.4% since, to $16 in 2025. That places this record below the midpoint for vascular surgery clinicians in IN, where the typical reported total is $4,328.

$1,489in general payments, 2019–2025

Across 19 payments — averaging $78.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Shape Memory Medical Inc.$490
  • Cook Medical LLC$303
  • Bolton Medical Inc$302
  • Lemaitre Vascular, Inc.$221
  • Abbott$102
  • Medtronic$24
  • plus $47 from 3 others
$244,665in research payments, 2019–2025

Across 11 payments — averaging $22,242 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Solventum Corporation$223K
  • Bard Peripheral Vascular, Inc.$21K

What the payments were for

  • Travel & lodging$40627%
  • Food & beverage$1,08373%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,489 in reported general payments places this provider in the 30th percentile of 71 vascular surgery providers in Indiana.

See all vascular surgery providers in Indiana

Medicare billing

Part B allowed, 2024
$110,867
Medicare patients
479
Services billed
976

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban24$23,154
EliquisApixaban12$10,518
Cilostazol37$826
Gabapentin18$392
Atorvastatin Calcium40$356
ClopidogrelClopidogrel Bisulfate28$166

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →